India

BMI believes Bangalore-based Strides Arcolab's impressive growth trajectory is set to continue. The drugmaker operates from a low-cost base, is present in over 60 developed states... 2010-03-05

Healthcare expenditure in India is expected to increase from INR2,088bn (US$46.4bn) in 2009 to INR2,326bn (US$55.7bn) in 2010. Due to the strengthening rupee, this equates to growth... 2010-02-18

India's Elder Pharmaceutical has exited its joint venture (JV) with Vincom Pharmaceuticals in Ghana due to low sales and delays to the tie-up's strategic plan. BMI believes that Ghana... 2010-01-18

Indian firm Strides Arcolab is to provide Pfizer with 40 off-patent sterile injectable and oral products for sale in the US. Because Strides Arcolab manufactures in a low-cost base... 2010-01-08

One of BMI's core views for the pharmaceutical industry is that Africa represents a long-term challenge and opportunity. The continent has a combined population of 1bn people and... 2009-12-22

BMI believes there are three main reasons for India's pharmaceutical sector failing, as yet, to develop a new molecular entity (NME). Its economy has been driven by agriculture rather... 2009-12-21

Local and multinational companies are increasingly targeting India's rural regions. The economy of this territory is sizeable and projected to expand steadily over the medium term.... 2009-12-17